Patient Care Law Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Patient Care Law Weekly


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Food and Drug Administration, U.S.

News from Food and Drug Administration, U.S., highlights the latest developments

This trend article is an immediate alert from NewsRx to identify the most recent news developments at Food and Drug Administration, U.S.

Report 1: The U.S. Food and Drug Administration (FDA) approved the use of Avastin (bevacizumab) in combination with carboplatin and paclitaxel for the initial systemic treatment of patients with unresectable, locally advanced, recurrent or metastatic, non-squamous, non-small cell lung cancer.

This approval was based on an improvement in survival time when Avastin was added to a standard chemotherapy regimen.

...

• View Other Issues of Patient Care Law Weekly
  
• View Other NewsRx Publications